Skip to content

Palliative pylorus-preserving pancreatic head resection and postoperative chemotherapy versus primary chemotherapy alone for patients with advanced carcinoma of the pancreatic head

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN20060588
Enrollment
20
Registered
2007-07-02
Start date
2003-09-15
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic head carcinoma Cancer Pancreatic head carcinoma

Interventions

Group 1: standard pylorus-preserving pancreatic head resection with regional lymphadenectomy (this is an internationally well accepted surgical procedure) and after completion of wound healing (up to

Sponsors

Humboldt University Berlin (Germany)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Medical centres experienced in surgical and medical care of patients with pancreatic head carcinoma.

Exclusion criteria

Exclusion criteria: No exclusion criteria.

Design outcomes

Primary

MeasureTime frame
Survival, measured after 3, 6 and 12 months

Secondary

MeasureTime frame
1. Quality of life, measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Cancer patients (EORTC QLQ-C30) and the EORTC Quality of Life Questionnaire for Pancreatic cancer (QLQ PAN26). This will be measured after 3, 6 and 12 months 2. Surgical complications, measured after 3, 6 and 12 months 3. Toxicity of chemotherapy, measured after 3, 6 and 12 months

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026